Mecom Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value |
|---|---|
| Gene Symbol | MECOM |
| Gene Name | MDS1 and EVI1 Complex (EVI1) |
| Chromosomal Location | 3q26.2 |
| NCBI Gene ID | 2122 |
| Ensembl ID | ENSG00000085276 |
| UniProt ID | Q03112 |
MECOM (EVI1) is a transcription factor involved in hematopoiesis and development. It regulates gene expression through multiple DNA-binding domains. MECOM variants are associated with PD risk, and the gene is implicated in neuronal survival and apoptosis. MECOM encodes a zinc finger transcription factor with multiple protein isoforms. The gene is named for its involvement in myeloid leukemia (ecotropic virus integration site 1). GWAS have identified MECOM variants associated with PD risk, though the mechanism is unclear. In neurons, MECOM may regulate genes involved in cell survival and stress responses. The protein can interact with SMAD proteins and modulate TGF-β signaling, which is important for neuronal function.
The MECOM gene encodes a protein involved in various neurological processes. This gene plays important roles in neuronal function, synaptic transmission, and cellular homeostasis in the brain.
| Disease | Notes |
|---|---|
| ALS |
Expression is detected in various brain regions including cortex, hippocampus, and cerebellum. Expression levels may be altered in neurodegenerative diseases.
Understanding the role of MECOM in neurodegeneration may lead to novel therapeutic approaches. Targeting this gene or its protein product could provide benefits for disease modification.
The MECOM gene (MDS1 and EVI1 Complex) encodes multiple protein isoforms through alternative splicing:
The gene spans approximately 60 kb on chromosome 3q26 and contains 16 exons.
EVI1 functions as a transcriptional regulator by:
Target genes include those involved in:
In the nervous system, MECOM is expressed in:
EVI1 in neurons may regulate:
GWAS have identified MECOM variants associated with PD risk:
Current research areas include:
Understanding the role of this entity in neurodegeneration is important for developing effective treatments. Research continues to uncover new therapeutic targets.
The study of Mecom Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gene information last updated: 2026-03-04